BAY 2927088 Bayer (CM), BAY 2927088 Bayer (CM), BAY 2927088, BAY 2927088 Bayer
22752
Phase 2 small_molecule active
Quick answer
BAY 2927088 Bayer (CM), BAY 2927088 Bayer (CM), BAY 2927088, BAY 2927088 Bayer for HER2 mutation, Advanced solid tumors is a Phase 2 program (small_molecule) at Bayer AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer AG
- Indication
- HER2 mutation, Advanced solid tumors
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active